The drug is now the only approved medicine in biomarker-selected patients with advanced pancreatic cancer.
Merck’s Rs440 a share special dividend is good news for investors but more so for its new parent P&G. After the dividend, life for investors will return to mundane things such as performance-driven valuations
The company had posted a net profit of Rs 31.68 crore for the corresponding period previous fiscal, Merck Ltd said in a BSE filing.
The Department of Pharmaceuticals has approved the proposal of Procter & Gamble Overseas India BV for acquisition of up to 77.80 percent of the paid-up equity share capital of the company, Merck Ltd said in a filing to BSE.
Merck has reported a sales total income from operations of Rs 220.29 crore and a net profit of Rs 48.31 crore for the quarter ended Jun-2018
This is subject to approval of the shareholders of the company and other statutory nods, Merck Ltd said in a filing to the BSE.
As part of the 3.4-billion euro (USD 4.2 billion) cash deal, some 3,300 staff will move from Merck to Procter & Gamble, it said in a statement.
We advise investors to avoid creating aggressive shorts at the current juncture and instead look to accumulate quality stocks in a staggered manner for the medium-term.
Centrum Research has recommended hold rating on Merck with a target price of Rs 1080 in its research report dated February 26, 2018.
With the sale, the total shareholding of the insurer has come down to 5.6 per cent, Merck Ltd said in a BSE filing.
Centrum recommended hold rating on Merck with a target price of Rs 1080 in its research report dated November 16, 2017.
Merck says Keytruda will come with “India Specific Pricing And Patient Access Programs”.
Kenneth Fraizer, the chief executive of drugmaker Merck and an African-American, said he left the advisory council because of the president's reaction after the violence between white supremacists and counter protesters. Frazier cited the need to "take a stand against intolerance and extremism."
The company's Q2 net profit declined 12 percent at Rs 20.1 crore versus Rs 22.8 crore, reported in the same quarter last fiscal.
The company had posted a net profit of Rs 22.78 crore for the corresponding period of the previous fiscal, Merck Ltd said in a filing to BSE.
The announcement that Merck, Pfizer and Corning have joined hands to drive manufacturing and create jobs by returning the USD 4 billion pharmaceutical glass manufacturing to the US "through modernisation and innovation" was made as part of the 'Made in America' week celebrations at the White House.
Drug firm Merck today reported a 76.42 percent increase in its net profit at Rs 14.82 crore for the quarter ended on March 31.
Centrum recommended hold rating on Merck with a target price of Rs 1020 in its research report dated March 01, 2017.
L&T | Idea Cellular | ONGC | HPCL | Coal India | Sambhaav Media | Quess Corp | Merck | Assam Company | NHPC | Kohinoor Foods | LT Foods | KRBL | Adani Enterprises | Varun Beverages and BEML are stocks, which are in the news today.
Drug firm Merck today reported a 25 percent rise in standalone net profit to Rs 18.20 crore for the quarter ended December 31, 2016.
"A section of the work force at the company's Goa plant have stopped work, while the company and the workers' union are engaged in negotiating the workers' charter of demand, which includes wage revision," Merck Ltd said in a BSE filing.
Infosys | Idea Cellular | Axis Bank | Tata Steel | Bharti Airtel | Bharat Forge | Hero Motocorp | Godawari Power | Jubilant Life Sciences | NHPC | Quess Corp | Titan Company and Jindal Stainless are stocks, which are in the news today.
Twenty-two companies, including Pfizer, Merck, Novartis, Roche, Sanofi and GlaxoSmithKline, will contribute funds and expertise to the project, which is backed by the World Bank.